Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Biliary Cholangitis Without Cirrhosis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating cilofexor in adults with primary biliary cholangitis without cirrhosis; study terminated with posted results in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Cilofexor (cilofexor)

Snippet

Sponsor: Gilead Sciences | Conditions: Primary Biliary Cholangitis | Phase 2 | Status: TERMINATED | Results posted: 2020-01-13